Sign in to baba News

One account across the web, iPhone and Android — your subscription follows it.

or use an email code

Welcome — one more step

News Plus opens the cross-newsroom layer — who covered a story, who didn’t, and how each one worded it.

  • Ask Duki without the monthly limit — answers from the coverage, with sources
  • Save articles, synced between the web and the app
  • Every Not Everywhere story, no daily limit
  • How each newsroom worded the same event
  • Filing timeline and coverage breakdown
  • The whole archive, searchable
  • Unlimited newsroom, topic and people follows
  • The daily brief by email, in English or Hebrew

Eligible new subscribers get 7 days free, then $34.99 each year. Renews automatically until cancelled. Cancel any time in your account. Subscription terms.

Your subscription also unlocks the app.

Search stories

Type at least two characters. Results come from every newsroom baba reads.

to move · to open · esc to close

Live Terminal

Sign in to baba News

Sign in to keep asking. News Plus removes the daily limit.

or use an email code

Keep the whole picture

News Plus opens the cross-newsroom layer — who covered a story, who didn’t, and how each one worded it.

  • Ask Duki without the monthly limit — answers from the coverage, with sources
  • Save articles, synced between the web and the app
  • Every Not Everywhere story, no daily limit
  • How each newsroom worded the same event
  • Filing timeline and coverage breakdown
  • The whole archive, searchable
  • Unlimited newsroom, topic and people follows
  • The daily brief by email, in English or Hebrew

Eligible new subscribers get 7 days free, then $34.99 each year. Renews automatically until cancelled. Cancel any time in your account. Subscription terms.

Your subscription also unlocks the app.

Economy06:17 · Jul 27

Kibbutz Maabarot Shuts Down Terima Pharmaceutical Company After 85 Years

By גולן חזני
Translated & summarized from Calcalist by baba
Kibbutz Maabarot Shuts Down Terima Pharmaceutical Company After 85 Years
Editorial illustration generated by baba News — not a photograph of the event.
The story · English

Terima, a historic pharmaceutical company founded 85 years ago by Israel's first president, Chaim Weizmann, is closing its operations. The company, currently owned by Kibbutz Maabarot, informed its approximately 130 employees last night that after extensive efforts to find a buyer or alternative solutions, the kibbutz decided to cease Terima's production activities. The decision followed unsuccessful attempts to sell the company as a whole while ensuring its continued operation. Terima is best known for marketing Postinor, the emergency contraceptive pill dominating Israel's birth control market. Import products, including Postinor, will be transferred to Altman, a natural health products company also fully owned by Kibbutz Maabarot. Previous efforts to sell Terima, which has been losing between 10 and 20 million shekels annually, to Rafa (backed by FIMI fund) and to Kafatz (backed by Fortissimo fund) fell through. Terima was acquired by Kibbutz Maabarot in 1962, and most of its employees work outside the kibbutz. The closure marks the end of an era in Israel's pharmaceutical industry.

Read the original at Calcalist
Open the live terminal